Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma-Reference-Cited by-同舟云学术

Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma

Published:2005-08-15 Issue:47 Volume:24 Page:7073-7083
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Somasundaram Kumaravel,Reddy Sreekanth P,Vinnakota Katyayni,Britto Ramona,Subbarayan Madhavan,Nambiar Sandeep,Hebbar Aparna,Samuel Cini,Shetty Mitesh,Sreepathi Hari Kishore,Santosh Vani,Hegde Alangar Sathyaranjandas,Hegde Sridevi,Kondaiah Paturu,Rao M R S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1208865.pdf

Reference79 articles.

1. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de Angelis M, Lendahl U and Edlund H . (1999). Nature, 400, 877–881.

2. Artavanis-Tsakonas S, Matsuno K and Fortini ME . (1995). Science, 268, 225–232.

3. Artavanis-Tsakonas S, Rand MD and Lake RJ . (1999). Science, 284, 770–776.

4. Bae SK, Bessho Y, Hojo M and Kageyama R . (2000). Development, 127, 2933–2943.

5. Ball DW, Azzoli CG, Baylin SB, Chi D, Dou S, Donis-Keller H, Cumaraswamy A, Borges M and Nelkin BD . (1993). Proc. Natl. Acad. Sci. USA, 90, 5648–5652.

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the mosaic: Epigenetic diversity in glioblastoma;Molecular Oncology;2024-08-15

2. Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer;Molecular Cancer Research;2024-03-21

3. ASCL1-ERK1/2 Axis: ASCL1 restrains ERK1/2 via the dual specificity phosphatase DUSP6 to promote survival of a subset of neuroendocrine lung cancers;2023-06-15

4. SeATAC: a tool for exploring the chromatin landscape and the role of pioneer factors;Genome Biology;2023-05-22

5. Genetic Inactivation of Notch1 Synergizes with Loss of Trp53 to Induce Tumor Formation in the Adult Mouse Forebrain;Cancers;2022-11-02